Form Approved
OMB No. 0920-xxxx
Exp. Date xx/xx/xxxx
Case Study Guide
Evaluation of CDC’s CCC 1017 Program
A. Interview Introduction
First of all, thank you for making time to meet with us today. We know you are a busy person and we appreciate your cooperation.
Before we get started with the interview I would like to tell you about the study we are doing and how we would like for you to be involved, and I’ll give you a chance to ask questions if you have any. Once I am done with that, I would like to confirm that you are willing to participate and then we will get started!
Administer the informed consent form and obtain signed consent and permission to audio record interview if possible.
If consent provided:
Thank you for agreeing to participate!
We are excited to be part of this national effort to advance cancer prevention and control, and we are interested in learning more about your perspective and experiences.
B. Key Informant Information
Role in PSE Change Strategies
1. Could you tell us about how you’ve been involved with policy, systems, and environmental change strategies related to cancer prevention and control in <jurisdiction>?
2. How did you get involved?
3. How long have you been involved?
C. Planning and Assessment (Wave 1)
Stage of the 1017 Program: Preparation Stage, Prioritization Stage
Stage of PSE Change: PSE Development
EQ2. How did 1017 programs build infrastructure required to develop a PSE agenda, evaluation plans, and media plans?
a. Public health staff and resources
b. Partners
c. TA and training
d. Data, evidence, and evaluation
e. Leadership
Topic Elaboration Questions |
Interview Topics/Questions |
CCC Program Leadership |
PSE Coordinator |
CCC Program Staff |
Workgroup Members |
Community Members |
What role did the CCC PD play during planning? How did HD leadership support the planning process? |
Leadership:
|
Yes |
Yes |
Yes |
? |
|
Were CCC programs able to hire and retain a PSE Coordinator? If not, why? What competencies and skills did the PSE Coordinator bring to the CCC program? |
PSE Coordinator:
|
Yes |
? |
? |
? |
|
What other CCC program staff contributed to the 1017-related activities and in what roles? What competencies and skills did they bring? |
Program Staff:
|
Yes |
Yes |
? |
|
|
How did the CCC programs identify and engage partners? |
Partners:
|
Yes |
Yes |
? |
Yes |
? |
What was the composition of the PSE Workgroup and how did it change over time (size; sectors represented; knowledge, skills, and connections represented)? How was the PSE Workgroup organized? (e.g., steering committee, workgroups, leadership)? |
PSE Workgroup:
|
Yes |
Yes, if applicable |
|
Yes |
|
What was the process for obtaining individual TA or ad hoc support? Which training methods were considered effective? Which were not considered effective? How did training of CCC staff “trickle down” to partners? |
Technical Assistance & Training:
|
Yes |
Yes |
Yes |
? |
? |
How were cancer burden data, community input, and environmental scan data used to select priorities and prepare the PSE agenda and media plan? Did partners provide any data or evidence that would not have been available to the program without their involvement in the PSE Workgroup? |
Priority Setting and Planning:
|
|
Yes |
Yes |
Yes |
|
EQ3. How did 1017 programs plan to advance their PSE goals?
a. What PSE priorities were chosen for their PSE agendas (by topic, sector, strategy and stakeholder and decision maker type)?
b. How well did the PSE agendas align with data, evidence, community input?
c. How well did the PSE agendas align with CCC and other chronic disease plans?
d. What level of engagement and support did partners have with plan development and priorities?
e. How responsive was the plan to local context?
Topic Elaboration Questions |
Interview Topics/Questions |
CCC Program Leadership |
PSE Coordinator |
CCC Program Staff |
Workgroup Members |
Community Members |
How were PSE change strategies identified and prioritized? |
|
Yes |
Yes |
|
Yes |
|
How did priorities differ from pre-1017 priorities? Specifically, how did the mix of primary, secondary, and tertiary prevention strategies differ from pre-1017 priorities? |
|
Yes |
? |
Yes |
? |
|
What characteristics of the local context were taken into account during the plan development process? |
|
Yes |
Yes |
? |
Yes |
|
EQ 11. What type of engagement and support did PSE Workgroups have with plan development and priority setting?
a. What were the roles and responsibilities of the PSE Workgroup for plan development and priority setting?
b. How did member composition influence selection of strategies?
Topic Elaboration Questions |
Interview Topics/ Questions |
CCC Program Leadership |
PSE Coordinator |
CCC Program Staff |
Workgroup Members |
Community Members |
How and at what level did the PSE Workgroup contribute to the planning process, especially in relation to assessment, priority setting, and selection of strategies? |
Probe for contributions to: - assessment - priority setting - strategy selection |
Yes |
Yes |
? |
Yes |
|
For which steps of the planning process was the PSE Workgroup involvement most or least important? |
|
Yes |
Yes |
? |
Yes |
|
Were there key champions for the priorities within the PSE Workgroup? If so, who were they and how did they mobilize support? |
|
Yes |
Yes |
? |
Yes |
|
Was there consensus around the priorities? Why or why not? |
|
Yes |
Yes |
? |
Yes |
|
Who were the additional partners (non PSE Workgroup) that played a key role in planning? What did they do? |
|
Yes |
Yes |
? |
Yes |
|
How did 1017 staff engage the PSE Workgroup members at different steps of the planning process? |
|
Yes |
Yes |
? |
Yes |
|
D. Implementation (Wave 1 and 2)
Stage of the 1017 Program: Implementation Stage
Stage of Policy Development: Increased Awareness, Strengthened Support for PSE, PSE Change Implementation
EQ4. What methods were used by 1017 programs to implement the PSE agenda and media plan?
a. By topic
b. By audience
c. Roles of public health staff and partners
NOTE: Refer to the Case Profile for the list of implementation methods outlined in the PSE agenda and media plan. If PSE agenda and media plan are NOT available before site visit, or do not specify methods, then try to obtain copies (electronic preferred) and clarify methods being used during the interview.
Topic Elaboration Questions |
Interview Topics/ Questions |
CCC Program Leadership |
PSE Coordinator |
CCC Program Staff |
Workgroup Members |
Community Members |
What methods were actually used to implement the PSE agenda? What role did staff play during implementation? What were the key roles played by partners?
|
|
Yes |
Yes |
? |
Yes |
|
What strengths did staff/partners bring to the implementation of selected methods? |
|
Yes |
Yes |
Yes |
Yes |
? |
EQ12. How did PSE Workgroups facilitate implementation and achievement of PSE change?
a. What were the roles and responsibilities of the PSE Workgroups for implementation of PSE change strategies?
b. How did member composition influence the adoption of PSE changes strategies at the state and local level?
Topic Elaboration Questions |
Interview Topics/ Questions |
CCC Program Leadership |
PSE Coordinator |
CCC Program Staff |
Workgroup Members |
Community Members |
What role did the PSE Workgroup play for the implementation of the plan [or PSE agenda and media plan?]? |
|
Yes |
Yes |
? |
Yes |
|
What specific knowledge, skills, and relationships did the PSE Workgroup members bring to their roles related to implementation? |
Probe for: - specific knowledge, skills - resources provided - relationships to other stakeholders |
Yes |
Yes |
? |
Yes |
|
Who were the additional partners (non PSE Workgroup) that played a key role in implementation? What did they do? |
|
Yes |
Yes |
? |
Yes |
|
EQ5. What factors facilitated or hindered implementation of PSE agendas and media plans? How were barriers addressed by 1017 programs?
a. Role of context: socioeconomic, political, programmatic
b. Coalition functioning (trust, communication, structure, etc)
Topic Elaboration Questions |
Interview Topics/ Questions |
CCC Program Leadership |
PSE Coordinator |
CCC Program Staff |
Workgroup Members |
Community Members |
In what ways did external community or political events play a role in the implementation of 1017 priorities? In what ways did internal HD (leadership, staffing, budgets) or programmatic events (CCC, tobacco, other) affect the implementation of 1017 priorities? How did staff and partners respond to those events? |
Probe for: -Key political or economic events or conditions that made it possible to get traction on an issue? - Opposing or competing issues that made it impossible to get your issue on the decision maker’s agenda?
|
Yes |
Yes |
Yes |
Yes |
? |
How did the CCC coalition support or hinder implementation of the PSE agenda and media plan? |
-Which parts? -How? |
Yes |
Yes |
? |
Yes |
? |
EQ6. How were evaluation results used by 1017 programs to shape implementation?
EQ8. What strategies and methods were evaluated by 1017 programs? Which did they find to be most effective?
NOTE: If an evaluation plan is available prior to the site visit, review the plan beforehand and only ask questions where more information is needed. If the evaluation is NOT available prior to the site visit, ask program staff (or relevant partners) if one is available and obtain a copy for project records (electronic format preferable).
Topic Elaboration Questions |
Interview Topics/ Questions |
CCC Program Leadership |
PSE Coordinator |
CCC Program Staff |
Workgroup Members |
Community Members |
How were strategies evaluated? What evidence links specific methods to outcomes? |
If evaluation plan not available prior to site visit:
|
Yes |
Yes |
Yes |
? |
|
Did the evaluation plan include an implementation evaluation? What aspects of PSE agenda and media plan implementation were evaluated? |
If evaluation plan not available prior to site visit:
|
Yes |
Yes |
Yes |
? |
|
How were evaluation results shared? |
|
Yes |
Yes |
Yes |
Yes |
? |
What actions were taken as the result of the implementation evaluation? |
|
Yes |
Yes |
Yes |
? |
|
How do participants perceive the effectiveness of various strategies? Why were specific methods effective? |
|
Yes |
Yes |
? |
Yes |
? |
How well will successful strategies translate to other contexts? |
|
Yes |
Yes |
? |
Yes |
? |
EQ13. How do states/programs evaluate their partnerships?
Topic Elaboration Questions |
Interview Topics/ Questions |
CCC Program Leadership |
PSE Coordinator |
CCC Program Staff |
Workgroup Members |
Community Members |
What methods did they use? |
If evaluation plan not available prior to site visit:
|
Yes |
Yes |
Yes |
? |
|
What was their capacity for evaluation? |
|
Yes |
Yes |
Yes |
? |
|
D. Outcomes (Wave 2)
EQ7. What key PSE outcomes were achieved by 1017 programs?
a. Internal: Increased strategic capacity;
Sustainability of coalitions and strategic partnerships.
b. External: Shifts in awareness, political will, and active support on the part of stakeholders and decision makers;
PSE changes by topic, sector, level of prevention, and chronic disease prevention domain.
Topic Elaboration Questions |
Interview Topics/ Questions |
CCC Program Leadership |
PSE Coordinator |
CCC Program Staff |
Workgroup Members |
Community Members |
Were new strategic alliances formed? If so, what were they? What types of collaborative actions among organizations occurred (joint meetings, aligned messages)? |
|
Yes |
Yes |
|
Yes |
? |
Were new partners brought into CCC? If so, who were they? What types of collaborative actions among organizations occurred (joint meetings, aligned messages)? |
|
Yes |
Yes |
|
Yes |
? |
How were additional resources leveraged (what kind? from where?) |
Probe for: - What kinds of resources? -From where? |
Yes |
Yes |
? |
Yes |
? |
How were relationships with elected officials affected? |
Probe for examples, if any. |
Yes |
Yes |
|
Yes |
Yes |
How were strategic partnerships being sustained? |
|
Yes |
Yes |
|
Yes |
? |
How was capacity built in the 4 chronic disease domains? |
Probe for improvements, if any, for each of the 4 chronic disease domains. |
Yes |
Yes |
Yes |
? |
|
Did stakeholder support increase for specific PSE changes? |
|
|
Yes |
|
Yes |
Yes |
Did the support of key decision makers around specific PSE change increase? |
|
|
Yes |
|
Yes |
Yes |
EQ9. What PSE changes were achieved at different points in time during the 5-year funding period?
Topic Elaboration Questions |
Interview Topics/ Questions |
CCC Program Leadership |
PSE Coordinator |
CCC Program Staff |
Workgroup Members |
Community Members |
What were the early “wins”? |
|
Yes |
Yes |
|
Yes |
|
Why were these successes achieved when they were? What were the key factors that led to each success? Prevented earlier success?
|
|
Yes |
Yes |
|
Yes |
|
What timelines are reasonable for selected PSE strategies to be achieved? |
|
Yes |
Yes |
|
Yes |
|
E. Coalition Functioning (Wave 1 and 2)
Stage of the 1017 Program: Preparation Stage, Prioritization Stage, Implementation Stage
Stage of Policy Development: Policy Development, Increased Awareness, Strengthened Support for PSE, PSE Change Implementation
EQ10. What was the relationship between PSE Workgroup, CCC coalitions, and other chronic disease coalitions?
NOTE: For these questions you will need to review the Case Profile for information on the PSE Workgroup.
Topic Elaboration Questions |
Interview Topics/ Questions |
CCC Program Leadership |
PSE Coordinator |
CCC Program Staff |
Workgroup Members |
Community Members |
How much and in what way did the PSE Workgroup interact with the CCC coalition during planning? During implementation? |
Probe for: - frequency of interactions - interactions during planning stage - interactions during implementation stages |
Yes |
Yes |
|
Yes |
|
How much and in what way did the PSE Workgroup interact with other coalitions during planning? During implementation? |
Probe for: - frequency of interactions - interactions during planning stage - interactions during implementation stages |
Yes |
Yes |
|
Yes |
|
How did the interaction facilitate or hinder advancement of PSE change? |
|
Yes |
Yes |
|
Yes |
|
Public reporting burden of this collection of information is estimated to vary between 60 and 90 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer, 1600 Clifton Road NE, MS D-74, Atlanta, GA 30333, ATTN: PRA (0920-xxxx).
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | John Rose |
File Modified | 0000-00-00 |
File Created | 2021-01-24 |